Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 729 M813 M803 M747 M861 M 3.22 B Research & development 153 M161 M151 M160 M143 M 615 M Operating income 629 M903 M539 M101 M259 M 1.8 B Non-Operating Income, Total 11 M31 M-9 M-24 M7 M 5 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 11 M31 M-9 M-24 M7 M 5 M Unusual income/expense ————— — Pretax income 548 M812 M433 M5 M170 M 1.42 B Equity in earnings 44 M78 M60 M47 M31 M 216 M Taxes 111 M162 M-1 M-32 M-96 M 33 M Non-controlling/minority interest 25 M42 M27 M9 M27 M 105 M After tax other income/expense 52 M-5 M140 M-229 M39 M -55 M Net income before discontinued operations 412 M608 M407 M28 M239 M 1.28 B Discontinued operations 0-17 M21 M25 M-1 M 28 M Net income 412 M591 M428 M53 M238 M 1.31 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 412 M591 M428 M53 M238 M 1.31 B Basic earnings per share (Basic EPS) 0.470.690.50.080.29 1.56 Diluted earnings per share (Diluted EPS) 0.470.680.50.070.28 1.53 Average basic shares outstanding 866.9 M854.9 M848.8 M852.4 M835 M — Diluted shares outstanding 878.3 M866.3 M858.6 M862.4 M842.8 M — EBITDA 771 M1.02 B723 M938 M457 M 3.13 B EBIT 563 M795 M495 M54 M240 M 1.58 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 208 M221 M228 M884 M217 M 1.55 B